Loading...
Tenova Pharmaceuticals | SKU:
T55054-5mg
BI-3802
$390.00
Unit price
/
Unavailable
BI-3802 - 5mg is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
BI-3802 is a highly potent BCL6 degrader and inhibits the Bric-a-brac (BTB) domain of BCL6 with an IC50 of ?3 nM. BI-3802 induces the polymerization of BCL6 and promotes BCL6 degration depended on E3 ligase SIAH1. BI-3802 has antitumor activity.
| Product Name | BI-3802 |
| Synonyms | |
| CAS Number | 2166387-65-9 |
| Related CAS | |
| Molecular Formula | C25H31ClN6O3 |
| Molecular Weight | 499.01 |
| SMILES | CNC(=O)COC1=CC2=C(C=CC(=C2)N(C)C2=NC(=NC=C2Cl)N2C[C@@H](C)C[C@@H](C)C2)N(C)C1=O |
| Purity (HPLC) | >= 95% |
| Physical Appearance | White solid |
| Solubility | DMSO, DMF |
| Shipping Conditions | Room Temperature |
| Storage Conditions | Refrigerated |
| Shelf Life | 12 months after the date of delivery |
| Regulatory Statement | For Research Use Only |
References
Rana, S.,Natarajan, A., Small molecule induced polymerization of BCL6 facilitates SIAH1 mediated degradation. Signal Transduction and Targeted Therapy, 2021, 6, 142.
Documents
Datasheet COA MSDS
Citations
If you know of a paper that uses this product from Tenova Pharma, please let us know.
